Caribbean Development Bank and EIB announce EUR 30m (USD 36m) in financing for affordable access to vaccines and new healthcare investments across the region
20 July 2021
Caribbean Development Bank (CDB) and the European Investment Bank (EIB) have partnered to provide EUR 30 million (USD 36 million) in financing to Caribbean countries to purchase COVID-19 vaccines and make new healthcare investments.
The concessional funding will help ensure the affordability of the vaccine purchases and public healthcare expenditure at this critical time for the region.
CDB and EIB’s cooperation spans four decades, and currently centres on climate action and resilience.
The Caribbean Development Bank (CDB) and European Investment Bank (EIB) are partnering to provide EUR 30 million (USD 36 million) to CDB’s Borrowing Member Countries (BMCs) for health-related emergency expenditure, including the purchase of vaccines against COVID-19, investments in healthcare, and efforts to limit the spread of the virus. The funding will help protect vulnerable groups and accelerate the region’s return to normal economic activities.
The financing will strengthen the public health systems that are dealing with the pandemic including, improving capacity for testing, tracing and treatment, logistics, storage, transport and monitoring activities as well as the purchase of vaccines and the execution of vaccination campaigns. The concessional financing falls under the broader CDB-EIB cooperation to improve resilience in the region.
President of CDB, Gene Leon and Vice President of the EIB, Ricardo Mourinho Félix announced the agreement today at a virtual signing ceremony.
“The Region has been severely impacted by the COVID 19 pandemic. Job losses have reached unprecedented levels; foreign exchange and remittance flows have been disrupted, and traditional revenue sources have dried up whilst Government’s COVID-related expenditures have risen sharply.” CDB President, Dr. Gene Leon said.
“CDB welcomes the partnership with the EIB. Through this support, we will be able to deliver vaccines and health services to our populations, thereby preparing the groundwork for the safe conduct of industrial, commercial and social activities,” he added.
“By spreading the cost of vaccinating the population over time, and by providing new funding for health-sector interventions, the CDB-EIB partnership will help Caribbean countries protect vulnerable groups against the impact of COVID-19,” stated EIB Vice President Ricardo Mourinho Félix. “This complements the EUR 500 million in funding the EU has provided for Gavi, the global Vaccine Alliance, to support affordable and equitable access to vaccines for 92 countries around the world, including six in the Caribbean - Dominica, Grenada, Guyana, Haiti, Saint Lucia, and St. Vincent and the Grenadines.”
Commenting on the agreement, EIB President, Werner Hoyer said, “Strong international cooperation is essential for ending the COVID-19 crisis, and to unlocking a global economic and social recovery. Since the outbreak of the pandemic, the European Investment Bank has worked with a range of partners globally to ensure a rapid and targeted response. As part of Team Europe, the EIB has already supported COVAX to make vaccines available in low and middle income countries through our largest ever financing for public health. The agreement with CDB today represents a key step to enable a faster recovery in the Caribbean region.”
Team Europe and COVAX
The proposed emergency financing is part of the policy and operational response of the EIB, in close cooperation with the European Commission (EC), to the COVID-19 epidemic breakout outside the EU. It is part of the EIB contribution to the Team Europe response to the COVID-19 crisis.
This initiative complements the grant of EUR 8 million (USD 8.6 million) the EU gave the Caribbean Public Health Agency (CARPHA) to help coordinate the regional response to combat the outbreak. EUR 1.9 million of this funding was used for vaccine purchases through COVAX, the global facility that reduces the cost of vaccines and equitably distributes these to participating countries.
CDB and EIB cooperation
CDB and EIB’s cooperation currently centres on climate action and resilience and spans four decades. In the last 10 years, USD 120 million in concessional finance has been made available for climate action projects across the Caribbean such as water supply investments, energy efficiency, green energy, flood protection and climate resilient communities.
The COVID-19 funding will be managed by CDB through its regular lending operations with its BMCs. It will finance operational and capital expenditures aimed at strengthening the emergency response against the COVID–19 crisis, and at increasing future pandemic preparedness of the Caribbean region. In particular, it will support the acquisition of vaccines and the deployment of vaccination campaigns.
The loan will also finance the equipment and, consumables (protective materials and equipment, hygiene and disinfection measures) purchased to tame the pandemic of COVID-19 in line with the relevant national pandemic or civil protection / disaster plans. Healthcare related investment under this partnership could include support for laboratory diagnostics equipment, oxygen generation systems and field hospitals systems for rapid emergency deployment.
The EIB in the Caribbean
The EIB is the largest multilateral public bank in the world and roughly 10% of its lending targets investments outside of the European Union. The EIB is the world’s largest international public bank and has supported development and economic activity in the Caribbean with loans and equity investment EUR 2 billion since its first operation in the region.
As the EU Bank, the EIB has been active in the Caribbean for 40 years, supporting public infrastructure and private sector development through its loans and technical assistance programs. The EIB is committed to putting EU climate goals into practice by partnering at a global scale, lending over EUR 26 billion euros to climate action and environmental sustainability projects last year, and providing over EUR 5 billion euros in COVID-response loans since the start of the pandemic.
The Caribbean Development Bank is a regional financial institution established in 1970 for the purpose of contributing to the harmonious economic growth and development of its BMCs. CDB’s total assets as at December 31, 2020 stood at US$3.64 billion (bn). These include US$2.12 bn of Ordinary Capital Resources and US$1.52 bn of Special Funds Resources. The Bank is rated Aa1 Stable by Moody’s, AA+ Stable by Standard & Poor’s and AA+ Negative by Fitch Ratings. Read more at caribank.org.
The European Union’s (EU) relationship with the Caribbean centres on trade, political, and development partnerships. On the development front, the EU is the Caribbean’s largest partner. Regarding trade, the EU signed the first regional Economic Partnership Agreement (EPA) in 2008 and is the region’s second largest trading partner.
The winners of the tenth edition of the Social Innovation Tournament’s (SIT) General Category are Magrid with first prize and Inclusive Education with second prize, while Cellugy (ecoFLEXY) and Orange Fiber won first and second place in the Special Category, which is dedicated to projects focusing on sustainable living. Orange Fiber is also the winner of the Audience Choice Award, the company that received the most votes from the audience watching the tournament online. Moreover, Orange Fiber and Vortex Bladeless were selected to attend the INSEAD Social entrepreneurship programme.
The European Investment Bank (EIB) has signed a €72 million loan agreement with the Lapland Hospital District (LSHP) in northern Finland. LSHP operates the Central Hospital in Rovaniemi and will use the financing for a major overhaul of the facilities, including the construction of a new psychiatric hospital. The original Central Hospital premises were commissioned in 1988, while the psychiatric hospital is located in a larger-than-needed former tuberculosis clinic 30 km away. With today’s space requirements, efficient workflows, legal requirements and modern design standards, this situation warranted an investment to modernise and improve the situation for patients and staff alike.
The European Investment Bank (EIB) has taken a further step forward in backing the Spanish and European biomedical sector. To this end, the EIB will provide Anaconda Biomed, a Barcelona-based medical device startup, with venture debt funding of up to €10 million to support the development of its second generation of catheter for the treatment of acute ischemic stroke (AIS). This is the second venture debt operation in Spain backed by European Guarantee Fund (EGF) — part of the €540 billion EU response to the economic impact of COVID-19.